{"id":"https://openalex.org/W4401413151","doi":"https://doi.org/10.1007/s00262-024-03776-5","title":"GP100 expression is variable in intensity in melanoma","display_name":"GP100 expression is variable in intensity in melanoma","publication_year":2024,"publication_date":"2024-08-06","ids":{"openalex":"https://openalex.org/W4401413151","doi":"https://doi.org/10.1007/s00262-024-03776-5","pmid":"https://pubmed.ncbi.nlm.nih.gov/39105816","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11303354"},"language":"en","primary_location":{"id":"doi:10.1007/s00262-024-03776-5","doi":"https://doi.org/10.1007/s00262-024-03776-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-024-03776-5","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s00262-024-03776-5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104110889","display_name":"Jacqueline E. Mann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline E. Mann","raw_affiliation_strings":["Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111284068","display_name":"Nitzan Hasson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitzan Hasson","raw_affiliation_strings":["Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082380048","display_name":"David G. Su","orcid":"https://orcid.org/0000-0002-8693-612X","observed_orcids":["https://orcid.org/0000-0002-8693-612X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David G. Su","raw_affiliation_strings":["Division of Surgical Oncology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Surgical Oncology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001635790","display_name":"Adebowale Adeniran","orcid":"https://orcid.org/0000-0001-9820-632X","observed_orcids":["https://orcid.org/0000-0001-9820-632X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adebowale J. Adeniran","raw_affiliation_strings":["Department of Pathology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059758317","display_name":"Keiran S.M. Smalley","orcid":"https://orcid.org/0000-0003-1089-9307","observed_orcids":["https://orcid.org/0000-0003-1089-9307"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keiran S. M. Smalley","raw_affiliation_strings":["Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089680427","display_name":"Dijana Djureinovic","orcid":"https://orcid.org/0000-0002-1852-5409","observed_orcids":["https://orcid.org/0000-0002-1852-5409"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dijana Djureinovic","raw_affiliation_strings":["Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067591137","display_name":"Lucia B. Jilaveanu","orcid":"https://orcid.org/0000-0001-8900-5083","observed_orcids":["https://orcid.org/0000-0001-8900-5083"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucia B. Jilaveanu","raw_affiliation_strings":["Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011421834","display_name":"David A. Schoenfeld","orcid":"https://orcid.org/0000-0002-5202-3744","observed_orcids":["https://orcid.org/0000-0002-5202-3744"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Schoenfeld","raw_affiliation_strings":["Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001175430","display_name":"Harriet M. Kluger","orcid":"https://orcid.org/0000-0002-4932-9873","observed_orcids":["https://orcid.org/0000-0002-4932-9873"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Harriet M. Kluger","raw_affiliation_strings":["Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA. Harriet.kluger@yale.edu","Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA. Harriet.kluger@yale.edu","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001175430"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":2.0916,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.90046796,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"73","issue":"10","first_page":"191","last_page":"191"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4740999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4740999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.4081999957561493,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.08720000088214874,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gp100","display_name":"gp100","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/melanocytes","display_name":"melanocytes","score":0.609000027179718},{"id":"https://openalex.org/keywords/tebentafusp","display_name":"tebentafusp","score":0.8619999885559082},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.8069999814033508},{"id":"https://openalex.org/keywords/hla","display_name":"HLA","score":0.3449999988079071},{"id":"https://openalex.org/keywords/immunotherapy-targets","display_name":"immunotherapy targets","score":0.4959999918937683},{"id":"https://openalex.org/keywords/expression-intensity","display_name":"expression intensity","score":0.3869999945163727},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.6650000214576721},{"id":"https://openalex.org/keywords/quantitative-immunofluorescence","display_name":"quantitative immunofluorescence","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6952165961265564},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.6115484833717346},{"id":"https://openalex.org/C2778236600","wikidata":"https://www.wikidata.org/wiki/Q592324","display_name":"Immunofluorescence","level":3,"score":0.573134183883667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5428251624107361},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5355731248855591},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3317592144012451},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2989998459815979},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.16028425097465515}],"mesh":[{"descriptor_ui":"D000096142","descriptor_name":"Cutaneous Malignant Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058951","descriptor_name":"gp100 Melanoma Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00262-024-03776-5","doi":"https://doi.org/10.1007/s00262-024-03776-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-024-03776-5","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11303354","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11303354","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11303354/pdf/262_2024_Article_3776.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"},{"id":"pmid:39105816","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39105816","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology, immunotherapy : CII","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s00262-024-03776-5","doi":"https://doi.org/10.1007/s00262-024-03776-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-024-03776-5","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G3276807266","display_name":null,"funder_award_id":"P50 CA121974","funder_id":"https://openalex.org/F4320308380","funder_display_name":"Yale University"},{"id":"https://openalex.org/G9000070285","display_name":null,"funder_award_id":"CA121974","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000856474","display_name":"Human and Translational Immunology Training Program","funder_award_id":"T32AI155387","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000896307","display_name":"Dual-isotope SPECT imaging and immunophenotyping of immune cells to determine response to immunotherapy","funder_award_id":"R01CA269349","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000905448","display_name":"Yale Clinical and Translational Science Award","funder_award_id":"UL1TR001863","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000912835","display_name":"Yale SPORE in Skin Cancer","funder_award_id":"P50CA121974","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401413151.pdf","grobid_xml":"https://content.openalex.org/works/W4401413151.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1570494660","https://openalex.org/W1732186091","https://openalex.org/W1989790390","https://openalex.org/W2030259772","https://openalex.org/W2057663047","https://openalex.org/W2069113016","https://openalex.org/W2089401318","https://openalex.org/W2097995306","https://openalex.org/W2103277177","https://openalex.org/W2143878396","https://openalex.org/W2150391295","https://openalex.org/W2753432434","https://openalex.org/W2769807461","https://openalex.org/W2913383852","https://openalex.org/W2945173342","https://openalex.org/W2966041852","https://openalex.org/W3043703771","https://openalex.org/W3052274084","https://openalex.org/W3072109384","https://openalex.org/W3181517727","https://openalex.org/W3200574709","https://openalex.org/W3216655800","https://openalex.org/W4206773095","https://openalex.org/W4319298179","https://openalex.org/W4379645133","https://openalex.org/W4386955471","https://openalex.org/W4395469408"],"related_works":["https://openalex.org/W3213130385","https://openalex.org/W2028217157","https://openalex.org/W3072109384","https://openalex.org/W3098652024","https://openalex.org/W2216128346","https://openalex.org/W1508383316","https://openalex.org/W2023646603","https://openalex.org/W2069113016","https://openalex.org/W2088278402","https://openalex.org/W4399128232"],"abstract_inverted_index":{"Drugs":[0],"or":[1],"cellular":[2],"products":[3],"that":[4],"bind":[5],"to":[6,29,53,157],"gp100":[7,20,39,75,98,150],"are":[8,134],"being":[9,64],"investigated":[10],"for":[11,31,59,97],"treatment":[12],"of":[13,19,74,92,116,143,149],"cutaneous":[14,67,79],"melanoma.":[15,68],"The":[16],"relative":[17],"specificity":[18],"expression":[21,76,99,151],"in":[22,49,56,66,77,103,129,136,155],"melanocytes":[23],"makes":[24],"it":[25],"an":[26],"attractive":[27],"target":[28],"harness":[30],"therapeutic":[32],"intent.":[33],"For":[34],"example,":[35],"Tebentafusp,":[36],"a":[37,89,121],"bispecific":[38],"peptide-HLA-directed":[40],"CD3":[41],"T":[42],"cell":[43],"engager,":[44],"has":[45,81],"generated":[46],"significant":[47],"enthusiasm":[48],"recent":[50],"years":[51],"due":[52],"its":[54],"success":[55],"improving":[57],"outcomes":[58],"uveal":[60],"melanoma":[61,80],"and":[62,72,94,109,146],"is":[63],"studied":[65,154],"However,":[69],"the":[70,114,127,139,144,147],"extent":[71],"intensity":[73,117],"advanced":[78],"not":[82],"been":[83],"well":[84],"studied.":[85],"Here,":[86],"we":[87,125],"interrogated":[88],"large":[90],"cohort":[91],"primary":[93],"metastatic":[95,104],"melanomas":[96],"by":[100],"immunohistochemistry.":[101],"Expression":[102],"samples":[105],"was":[106,118],"globally":[107],"higher":[108],"almost":[110],"uniformly":[111],"positive,":[112],"however":[113],"degree":[115],"variable.":[119],"Using":[120],"quantitative":[122],"immunofluorescence":[123],"method,":[124],"confirmed":[126],"variability":[128],"expression.":[130],"As":[131],"gp100-binding":[132],"drugs":[133,145],"assessed":[135],"clinical":[137],"trials,":[138],"association":[140],"between":[141],"activity":[142],"level":[148],"should":[152],"be":[153],"order":[156],"potentially":[158],"improve":[159],"patient":[160],"selection.":[161]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-08-09T00:00:00"}